Direct chemical synthesis has been adapted to make oligonucleotides of remarkable length, including an 800 nucleotide green ...
Primrose Bio intends to apply its broad competencies in nucleic acid synthesis and protein expression to provide novel manufacturing solutions to these molecules as well. By offering affordable ...
In response to this gap, leaders in the nucleic acid synthesis industry took a step towards self-regulation. In 2009, they formed the International Gene Synthesis Consortium (IGSC) and established a ...
The resulting RNA molecule, typically mRNA, carries the genetic message from the nucleus to the cytoplasm for protein synthesis. Nucleic acids are the foundation of genetic engineering techniques, ...
Participants may access the live webcast on the Codexis Investor Relations website, where it will be archived for 90 days. The live call can be accessed by dialing 877-705-2976 (domestic) or ...
The acquisition will expand Maravai and TriLink BioTechnologies' ability to enable customers to develop next-generation mRNA and CRISPR nucleic acid-based therapies. “Molecular Assemblies is the ...
SAN DIEGO - Maravai LifeSciences, Inc. (NASDAQ: MRVI), a $796 million market cap company known for supplying life science reagents and services, has announced the acquisition of intellectual property ...
This distribution partnership is expected to improve the ordering process and offer shorter lead times for European customers -- increasing access to TriLink’s novel nucleic acid technologies.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback